Ayala Pharmaceuticals Inc (ADXS)

[cdiddy01]

I tend to agree with you. There's no doubt they've seen some data at this point and while still early, they may not have been enamored with what they saw. Add to that the potential high costs of manufacturing and that combined led them to pull the plug. There's no doubt if the data was amazing they would have found a way to continue.

However, this notion that Amgen just got outplayed or "annoyed" by Advaxis because of their shrewd foresight in navigating HOT around them seems ludicrous. Not a 20 million dollar market cap company who has seen 3 CEO's over the last 1.5 years and failed to sign any sort of deal for 2.5. It's bonkers to even think it, imo.